BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 35887589)

  • 1. Eosinophilic Asthma, Phenotypes-Endotypes and Current Biomarkers of Choice.
    Porpodis K; Tsiouprou I; Apostolopoulos A; Ntontsi P; Fouka E; Papakosta D; Vliagoftis H; Domvri K
    J Pers Med; 2022 Jun; 12(7):. PubMed ID: 35887589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic Asthma.
    Nelson RK; Bush A; Stokes J; Nair P; Akuthota P
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):465-473. PubMed ID: 31786254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Airway molecular endotypes of asthma: dissecting the heterogeneity.
    Wesolowska-Andersen A; Seibold MA
    Curr Opin Allergy Clin Immunol; 2015 Apr; 15(2):163-8. PubMed ID: 25961390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma.
    Vatrella A; Maglio A; Pelaia C; Ciampo L; Pelaia G; Vitale C
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons.
    Hussain M; Liu G
    Cells; 2024 Feb; 13(5):. PubMed ID: 38474348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypes and endotypes of adult asthma: Moving toward precision medicine.
    Kaur R; Chupp G
    J Allergy Clin Immunol; 2019 Jul; 144(1):1-12. PubMed ID: 31277742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe asthma phenotypes and endotypes.
    Agache I
    Semin Immunol; 2019 Dec; 46():101301. PubMed ID: 31466925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying personalized medicine to adult severe asthma.
    Tiotiu A
    Allergy Asthma Proc; 2021 Jan; 42(1):e8-e16. PubMed ID: 33404396
    [No Abstract]   [Full Text] [Related]  

  • 9. Benralizumab in the treatment of severe asthma: design, development and potential place in therapy.
    Pelaia C; Vatrella A; Bruni A; Terracciano R; Pelaia G
    Drug Des Devel Ther; 2018; 12():619-628. PubMed ID: 29606855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity?
    Van Hulst G; Bureau F; Desmet CJ
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asthma phenotypes and endotypes.
    Lin TY; Poon AH; Hamid Q
    Curr Opin Pulm Med; 2013 Jan; 19(1):18-23. PubMed ID: 23114560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential.
    Menzella F; Lusuardi M; Galeone C; Taddei S; Facciolongo N; Zucchi L
    Ther Adv Chronic Dis; 2016 Nov; 7(6):260-277. PubMed ID: 27803792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted anti-inflammatory therapeutics in asthma and chronic obstructive lung disease.
    Durham AL; Caramori G; Chung KF; Adcock IM
    Transl Res; 2016 Jan; 167(1):192-203. PubMed ID: 26334389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. From phenotypes to endotypes to asthma treatment.
    Agache IO
    Curr Opin Allergy Clin Immunol; 2013 Jun; 13(3):249-56. PubMed ID: 23587683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory biomarkers for asthma endotyping and consequent personalized therapy.
    Ciprandi G; Tosca MA; Silvestri M; Ricciardolo FLM
    Expert Rev Clin Immunol; 2017 Jul; 13(7):715-721. PubMed ID: 28347164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precision medicine in asthma: linking phenotypes to targeted treatments.
    Chung KF
    Curr Opin Pulm Med; 2018 Jan; 24(1):4-10. PubMed ID: 29036018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving phenotypes to endotypes: is precision medicine achievable in asthma?
    Bagnasco D; Passalacqua G; Caminati M; Heffler E; Menzella F; De Ferrari L; Riccio AM; Folli C; Canonica GW
    Expert Rev Respir Med; 2020 Feb; 14(2):163-172. PubMed ID: 31899999
    [No Abstract]   [Full Text] [Related]  

  • 18. Asthma phenotyping: a necessity for improved therapeutic precision and new targeted therapies.
    Chung KF
    J Intern Med; 2016 Feb; 279(2):192-204. PubMed ID: 26076339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent insights in the role of biomarkers in severe asthma management.
    Fouka E; Domvri K; Gkakou F; Alevizaki M; Steiropoulos P; Papakosta D; Porpodis K
    Front Med (Lausanne); 2022; 9():992565. PubMed ID: 36226150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of T2 inflammation biomarkers in severe asthma.
    Parulekar AD; Diamant Z; Hanania NA
    Curr Opin Pulm Med; 2016 Jan; 22(1):59-68. PubMed ID: 26574724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.